Condition
Streptococcal Pneumonia
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03102840Unknown
Understanding Pneumococcal Carriage and Disease 2017-2020
NCT03331952CompletedPrimary
A Study of Streptococcus Pneumonia Colonisation and Invasive Disease in Cambodian Children
NCT03838497Phase 4CompletedPrimary
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults
NCT02538211Not ApplicableCompleted
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
NCT02133469Not ApplicableCompletedPrimary
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
Showing all 5 trials